Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia annotation

Br J Haematol. 2001 Feb;112(2):275-81. doi: 10.1046/j.1365-2141.2001.02560.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Bone Marrow / pathology*
  • Bone Marrow Transplantation
  • Child
  • Costs and Cost Analysis
  • Humans
  • Neoplasm, Residual / pathology*
  • Polymerase Chain Reaction
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Predictive Value of Tests
  • Prognosis

Substances

  • Antineoplastic Agents